Abstract
Get full access to this article
View all access options for this article.
References
1.
Leahy, E.
, et al.: The effect of quinidine and other oral antiarrhythmic drugs in serum digoxin . Ann. Int. Med. , 92 : 605 , 1980 .
2.
Kayden, H.
, et al.: The use of procainamide in cardiac arrhythmias . Circulation , 4 : 13 , 1951 .
3.
Kayden, H.
: The current status of procainamide in the management of cardiac arrhythmias . Prog. Cardiovasc. Dis. , 3 : 331 , 1961 .
4.
Bigger, J.
,
Husinbuttel, R.
: The use of procainamide and lidocaine in the treatment of cardiac arrhythmias . Prog. Cardiovasc.
11 : 515 , 1969 .
5.
McLord, M.
,
Taguchi, J.
: A study of the effect of procainamide hydrochloride in supraventricular arrhythmias . Circulation , 4 : 387 , 1951 .
6.
Patton, R.
, et al.: Large doses of procainamide for paroxysmal ventricular tachycardia . JAMA , 209 : 1221 , 1969 .
7.
Koch-Weser, J.
,
Klein, S.
: Procainamide dosage schedules, plasma concentrations and clinical effects . JAMA , 215 : 454 , 1971 .
8.
S. Kavalunis
, personal communication .
9.
Smith, T.
,
Kinkel, A.
: Plasma levels of procainamide after administration of conventional and sustained release preparations . Curr. Ther. Res. , 27 : 217 , 1980 .
10.
Giardina, E.
, et al.: Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparation . Am. J. Cardiol. , 46 : 855 , 1980 .
11.
L. Chafetz
, personal communication .
12.
M. Silverman
, personal communication .